The monitoring of medical device safety in South Korea is governed by the Ministry of Food and Drug Safety, commonly referred to as the MFDS. Manufacturers must comply with a vigilance system designed for post-market monitoring and adverse event reporting. Companies that fail to accurately report incidents could face severe financial penalties or even criminal sentences. Because Korean authorities do not accept ignorance as an excuse for failing to implement a vigilance system, manufacturers must remain proactive in their compliance efforts.
Adverse events occurring in South Korea must be reported to the MFDS if they lead to specific clinical outcomes or serious scenarios. Either the manufacturer or their Korean License Holder (KLH) is responsible for this notification.
If a recall is necessary, it must be classified as Class I, II, or III based on its severity, regardless of the original device classification.
The management of safety issues follows a structured sequence of actions to ensure the MFDS is informed of both the incident and the corrective response.
The reporting process begins by informing the Korean License Holder and the MFDS that a reportable adverse event has occurred. Manufacturers must then investigate the cause of the event and report all findings to the MFDS. If a recall is required, a recall plan must be submitted to the MFDS for review, including a strategy for informing consumers about associated risks and a document stating the reason for the recall.
Upon completion of the investigation, the final outcomes and corrective actions must be reported to the MFDS. All reports, along with any correspondence with the MFDS, must be added to the company's Quality Management System records. Furthermore, the KLH is responsible for including adverse events in annual reports submitted to the authority.
For international manufacturers, the KLH serves as the essential regulatory liaison in South Korea. The KLH is responsible for submitting adverse event reports and recall information to the MFDS on behalf of the manufacturer. They also ensure that vigilance procedures remain up to date with the latest Korean medical device regulations, such as MFDS Notification No. 2017-82.
Our team facilitates compliance with MFDS post-market requirements through the following specialized service modules.
If you are interested in our South Korea medical device vigilance services and wish to maintain your market standing, please feel free to contact us.
We're open for any suggestion or just have a chat with us.
Tel: Email: WhatsAPP